2 ASX healthcare shares to buy and hold forever

So far this year the S&P/ASX 200 Health Care (Index: ^AXHJ) (ASX: XHJ) has been a huge mover, climbing almost 18%.

Despite this sizeable gain, I still believe the healthcare sector has some great long-term investment options for investors to snap up today.

Here are two of my favourites:

The CSL Limited (ASX: CSL) share price has been on fire this year and climbed a whopping 30%. As a major part of the S&P/ASX 200 Health Care index, the leading biotherapeutics company’s gain has been a key catalyst to its outperformance.

Pleasingly, I believe it can continue to climb higher from here thanks to its leading immunoglobulins business and the strong demand it is experiencing. Furthermore, the company’s fledgling Seqirus influenza vaccine business has started to show its promise. Management expects the business to break-even in FY 2018. After which, I believe it will be onwards and upwards for it.

The Ramsay Health Care Limited (ASX: RHC) share price has also performed strongly this year, rising close to 8% year-to-date. Like CSL, I wouldn’t be put off by this gain. After all, Ramsay is arguably one of the best buy and hold investments on the Australian share market today in my opinion.

Especially with the global population aged 60 or above forecast to more than triple by 2050. I expect this to lead to a strong demand for healthcare services for at least the next two to three decades, which should put the company in a position to continue to deliver above-average earnings growth for the foreseeable future.

Finally, here are three more buy and hold shares I think are worth considering today.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool's in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool's Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand - and how quickly the share prices of these companies moves - we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Two New Stock Picks Every Month!

Not to alarm you, but you’re about to miss a very important event! Chief Investment Advisor Scott Phillips and his team at Motley Fool Share Advisor are about to reveal their latest official stock recommendation. The premium “buy alert” will be unveiled to members and you can be among the first to act on the tip.

Don’t let this opportunity pass you by – this is your chance to get in early!

Simply enter your email now to find out how you can get instant access.

By clicking this button, you agree to our Terms of Service and Privacy Policy. We will use your email address only to keep you informed about updates to our website and about other products and services we think might interest you. You can unsubscribe from Take Stock at anytime. Please refer to our Financial Services Guide (FSG) for more information.